Product class: Authorized package
Medicinal product class: For human use
Package code: 1278176
Name of medicinal product: ALFUZOSIN-TEVA
Active substances:
Alfuzosin
Estonian, English, Latin
ATC code: G04CA01
Dosage form: prolonged-release tablet
Route of administration: oral use
Strengh: 10mg
Amount in package: 30TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Treatment of the functional symptoms of benign prostatic hyperplasia (BPH).
Safety features: Yes
Summary of product characteristics (SPC):  (last updated 18 April 2023)
Package information leaflet (PIL): EST  (last updated 18 April 2023)
Labelling:  (last updated 18 April 2023)
Last imported to Estonia: 05 July 2024
Marketing authorization holder: Teva Pharma B.V. 
Marketing authorization number: 556507 
Marketing authorization issued on: 24 August 2007 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Percent Valid from Valid until Valid Diagnosis Doctor's speciality Primary Age Other
100  13/07/2024     Yes      No  until 4 years   
50  13/07/2024     Yes      No      
Reference price: 11.20 EUR 
Under reference price: Yes 
Reference price of daily dose: 0.28 EUR 
Entry/Changing date: 25 October 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription